Oracle Board Member's Million-Dollar Stock Sale Signals Executive Trading Activity

Rhea-AI Filing Summary

Oracle Corp director George H. Conrades reported a significant insider transaction on Form 4. On June 17, 2025, Conrades executed a sale of 8,169 shares of Oracle common stock at a price of $213.49 per share, representing a total transaction value of approximately $1.74 million.

Following the transaction, Conrades continues to hold 38,456 shares directly. The sale was reported through his attorney-in-fact, Aimee Weast, under a previously filed power of attorney. The transaction was executed as a direct ownership disposition, with no derivative securities involved in this filing.

This insider sale comes at a time when Oracle stock has shown significant value, with the share price above $200. The transaction reduces Conrades' direct holdings but maintains his substantial position in the company while serving as a director.

Positive

• None.

Negative

• Director George H. Conrades sold 8,169 shares worth approximately $1.74M at $213.49 per share, retaining 38,456 shares

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CONRADES GEORGE H

(Last) (First) (Middle)

C/O DELPHI ASSET MGMT CORPORATION

200 S. VIRGINIA ST., SUITE 625

(Street)

RENO NV 89501

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ORACLE CORP [ ORCL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/17/2025		S		8,169	D	$213.49	38,456	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Aimee Weast by Aimee Weast, Attorney in Fact for George H. Conrades (POA filed 6/4/19)	06/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many ORCL shares did Director George Conrades sell on June 17, 2025?

Director George H. Conrades sold 8,169 shares of Oracle (ORCL) common stock at a price of $213.49 per share on June 17, 2025.

How many ORCL shares does George Conrades own after his June 2025 transaction?

Following the reported transaction, George Conrades directly owns 38,456 shares of Oracle (ORCL) common stock.

What was the total value of ORCL shares sold by Conrades in June 2025?

The total value of the transaction was approximately $1.74 million, calculated from 8,169 shares sold at $213.49 per share.

What position does George Conrades hold at ORCL according to the Form 4?

According to the Form 4 filing, George H. Conrades serves as a Director of Oracle Corporation (ORCL). This is indicated by the 'X' marked in the Director box under the Relationship of Reporting Person(s) to Issuer section.

Who signed the Form 4 for ORCL Director George Conrades?

The Form 4 was signed by Aimee Weast as Attorney in Fact for George H. Conrades, under a Power of Attorney (POA) that was filed on June 4, 2019.